Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013–2014 in the United States
Author(s) -
Manjusha Gaglani,
Jessica Pruszynski,
Kempapura Murthy,
Lydia Clipper,
Anne Robertson,
Michael Reis,
Jessie R. Chung,
Pedro A. Piedra,
Vasanthi Avadhanula,
Mary Patricia Nowalk,
Richard K. Zimmerman,
Michael L. Jackson,
Lisa A. Jackson,
Joshua G. Petrie,
Suzanne E. Ohmit,
Arnold S. Monto,
Huong Q. McLean,
Edward A. Belongia,
Alicia M. Fry,
Brendan Flannery
Publication year - 2016
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiv577
Subject(s) - medicine , influenza vaccine , live attenuated influenza vaccine , pandemic , virus , vaccination , influenza a virus , confidence interval , inactivated vaccine , vaccine efficacy , virology , immunology , covid-19 , disease , infectious disease (medical specialty)
The predominant strain during the 2013-2014 influenza season was 2009 pandemic influenza A(H1N1) virus (A[H1N1]pdm09). This vaccine-component has remained unchanged from 2009.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom